INDOCONSEIndoco Remedies Limited· PharmaceuticalsLowNeutral
Announced Thu, 15 May · 15:43 IST

Indoco Remedies Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Indoco Remedies has informed the exchanges that it will hold an earnings conference call on Thursday, 22nd May 2025 at 3:30 PM IST to discuss its audited financial results for the quarter and full year ended 31st March 2025. The call will be represented by Managing Director Aditi Panandikar, Joint Managing Director Sundeep V Bambolkar, and CFO Pramod Ghorpade. The call is being arranged with Dolat Capital Market, which is also facilitating retail and institutional access via DiamondPass registration and international toll-free numbers.

Likely market impact

This is a routine procedural filing notifying the market about the upcoming earnings call. No material business or financial information is disclosed here, so there is no direct impact on the stock. Investors should watch the call on 22nd May for actual Q4 and FY25 results and management commentary.